Authors
Loading...
In vitro study demonstrates precise CRISPR/Cas9 correction of a heterozygous HNF1A mutation in patient hiPSCs, highlighting optimized protocols for monogenic disease modeling.
Skoczek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: